Evidence map›Paper›PMID 15681476›Full record

ArticleThe Journal of molecular diagnostics : JMD2005

Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors.

Sandy Devries, Sarah Nyante, Jim Korkola, Richard Segraves, Kentaro Nakao, Dan Moore, Hanik Bae, Monica Wilhelm, Shelley Hwang, Frederic Waldman

Abstract readComparative Study
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Array-CGH and breast cancer.Breast cancer research : BCR · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sandy DevriesCancer Center, Box 0808, University of California San Francisco, San Francisco, CA 94143-0808, USA.
Sarah Nyante
Jim Korkola
Richard Segraves
Kentaro Nakao
Dan Moore
Hanik Bae
Monica Wilhelm
Shelley Hwang
Frederic Waldman

Funding

Tissue and Outcomes CoreP50CA058207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRAY, JOE W. · 1992 to 2012
$32.7M
GENETIC MARKERS OF BLADDER CANCER PROGRESSIONR01CA089715 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALBERTSON, DONNA G · 2001 to 2012
$3.1M
Genomic Markers of Colon Cancer ProgressionR01CA092374 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI WALDMAN, FREDERIC M. · 2001 to 2005
$1.5M
NCI NIH HHS CA58207NCI NIH HHS CA89715NCI NIH HHS CA92374NCI NIH HHS P50 CA058207NCI NIH HHS R01 CA089715NCI NIH HHS R01 CA092374
6 · The paper itself

Abstract

Identification of prognostic and predictive genomic markers requires long-term clinical follow-up of patients. Extraction of high-quality DNA from archived formalin-fixed, paraffin-embedded material is essential for such studies. Of particular importance is a robust reproducible method of whole genome amplification for small tissue samples. This is especially true for high-resolution analytical approaches because different genomic regions and sequences may amplify differentially. We have tested a number of protocols for DNA amplification for array-based comparative genomic hybridization (CGH), in which relative copy number of the entire genome is measured at 1 to 2 mb resolution. Both random-primed amplification and degenerate oligonucleotide-primed amplification approaches were tested using varying amounts of fresh and paraffin-extracted normal and breast tumor input DNAs. We found that random-primed amplification was clearly superior to degenerate oligonucleotide-primed amplification for array-based CGH. The best quality and reproducibility strongly depended on accurate determination of the amount of input DNA using a quantitative polymerase chain reaction-based method. Reproducible and high-quality results were attained using 50 ng of input DNA, and some samples yielded quality results with as little as 5 ng input DNA. We conclude that random-primed amplification of DNA isolated from paraffin sections is a robust and reproducible approach for array-based CGH analysis of archival tumor samples.

Indexed as

Nucleic Acid Amplification TechniquesBreast NeoplasmsDNA, NeoplasmFemaleFixativesFormaldehydeHumansOligonucleotide Array Sequence AnalysisParaffin EmbeddingPrognosisReproducibility of ResultsDNA, NeoplasmFixativesFormaldehyde

Identifiers

PMID15681476
PMCPMC1867501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.